Avraham Pharmaceuticals Ltd., of Yavne, Israel, closed an investment round of about $4 million. Investors in the round include Yissum Research Development Co. Ltd., the technology transfer arm of the Hebrew University of Jerusalem, Pontifax, Clal Biotechnology Industries, Integra Holdings, Yissum's biotech holdings company, the Technion Research and Development Foundation Ltd. and others.